L’apolipoprotéine B dans l’évaluation du risque cardiovasculaire

Maud Ahmad, Allan D Sniderman, Robert A Hegele · 2023

Read L’apolipoprotéine B dans l’évaluation du risque cardiovasculaire by Maud Ahmad, Allan D Sniderman, Robert A Hegele (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10699312.txt.

Description

Maud Ahmad, Allan Sniderman, and Robert Hegele argue for a blood marker that counts harmful fat particles when judging heart risk. Their 2023 article, written in French, follows Canadian guidance from 2021. The marker, called Apo B, sits once on each harmful particle, so its level equals the particle count.

Particle count tracks artery disease more closely than cholesterol mass does. Trial data for statins and newer drugs show the marker predicts heart risk more precisely than standard cholesterol scores. Guidance sets clear thresholds for starting or stepping up therapy. The marker also brings practical gains in testing. The authors urge wider use of the count in routine risk checks.

Catalog record

CREATORMaud Ahmad, Allan D Sniderman, Robert A Hegele
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE4 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10699312

Browse the full library · About the Tower of Babel